{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T15:51:36Z","timestamp":1710517896512},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2006,5,1]]},"DOI":"10.1532\/ijh97.05173","type":"journal-article","created":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T06:09:57Z","timestamp":1149746997000},"page":"351-355","source":"Crossref","is-referenced-by-count":10,"title":["Antibody Responses Associated with the Graft-versus-Leukemia Effect in Adult T-Cell Leukemia"],"prefix":"10.1007","volume":"83","author":[{"given":"Masakatsu","family":"Hishizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Imada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoko","family":"Nishikori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyoshi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Tsudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. <i>Blood.<\/i> 1977;<b>50<\/b>:481-92.","DOI":"10.1182\/blood.V50.3.481.bloodjournal503481"},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Shimoyama M, Ota K, Kikuchi M, et al. Major prognostic factors of adult patients with advanced T-cell lymphoma\/leukemia. <i>J Clin Oncol.<\/i> 1988;<b>6<\/b>:1088-1097.","DOI":"10.1200\/JCO.1988.6.7.1088"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Utsunomiya A, Miyazaki Y, Takatsuka Y, et al. Improved outcome of adult T cell leukemia\/lymphoma with allogeneic haematopoietic stem cell transplantation. <i>Bone Marrow Transplant.<\/i> 2001;<b>27<\/b>:15-20.","DOI":"10.1038\/sj.bmt.1702731"},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Kami M, Hamaki T, Miyakoshi S, et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia\/lymphoma. <i>Br J Haematol.<\/i> 2003;<b>120<\/b>:304-309.","DOI":"10.1046\/j.1365-2141.2003.04054.x"},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Okamura J, Utsunomiya A, Tanosaki R, et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma. <i>Blood.<\/i> 2005;<b>105<\/b>:4143-4145.","DOI":"10.1182\/blood-2004-11-4193"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Fukushima T, Miyazaki Y, Honda S, et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma. <i>Leukemia.<\/i> 2005;<b>19<\/b>:829-834.","DOI":"10.1038\/sj.leu.2403682"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Hishizawa M, Imada K, Ishikawa T, Uchiyama T. Kinetics of proviral DNA load, soluble interleukin-2 receptor level and tax expression in patients with adult T-cell leukemia receiving allogeneic stem cell transplantation. <i>Leukemia.<\/i> 2004;<b>18<\/b>:167-169.","DOI":"10.1038\/sj.leu.2403204"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Sahin U, Tureci O, Schmitt H, et al. Human neoplasms elicit multiple specific immune responses in the autologous host. <i>Proc Natl Acad Sci U S A.<\/i> 1995;<b>92<\/b>:11810-11813.","DOI":"10.1073\/pnas.92.25.11810"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Watanabe H, Carmi P, Hogan V, et al. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. <i>J Biol Chem.<\/i> 1991;<b>266<\/b>:13442-13448.","DOI":"10.1016\/S0021-9258(18)98859-9"},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Koga H, Imada K, Ueda M, Hishizawa M, Uchiyama T. Identification of differentially expressed molecules in adult T-cell leukemia cells proliferating in vivo. <i>Cancer Sci.<\/i> 2004;<b>95<\/b>:411-417.","DOI":"10.1111\/j.1349-7006.2004.tb03224.x"},{"key":"E00011","unstructured":"Kiniwa Y, Fujita T, Akada M, et al. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma. <i>Cancer Res.<\/i> 2001;<b>61<\/b>:7900-7907."},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Hishizawa M, Imada K, Sakai T, Ueda M, Hori T, Uchiyama T. Serological identification of adult T-cell leukaemia-associated antigens. <i>Br J Haematol.<\/i> 2005;<b>130<\/b>:382-390.","DOI":"10.1111\/j.1365-2141.2005.05619.x"},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Bellucci R, Wu CJ, Chiaretti S, et al. Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens. <i>Blood.<\/i> 2004;<b>103<\/b>:656-663.","DOI":"10.1182\/blood-2003-07-2559"},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Hishizawa M, Imada K, Sakai T, Ueda M, Uchiyama T. Identification of APOBEC3B as a potential target for the graft-versus-lymphoma effect by SEREX in a patient with mantle cell lymphoma. <i>Br J Haematol.<\/i> 2005;<b>130<\/b>:418-421.","DOI":"10.1111\/j.1365-2141.2005.05604.x"},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Lossos IS, Jones CD, Warnke R, et al. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. <i>Blood.<\/i> 2001;<b>98<\/b>:945-951.","DOI":"10.1182\/blood.V98.4.945"},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"Jutras I, Reudelhuber TL. Prorenin processing by cathepsin B in vitro and in transfected cells. <i>FEBS Lett.<\/i> 1999;<b>443<\/b>:48-52.","DOI":"10.1016\/S0014-5793(98)01672-X"},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"Moin K, Day NA, Sameni M, Hasnain S, Hirama T, Sloane BF. Human tumour cathepsin B: comparison with normal liver cathepsin B. <i>Biochem J.<\/i> 1992;<b>285<\/b>:427-434.","DOI":"10.1042\/bj2850427"},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Mach L, Schwihla H, Stuwe K, Rowan AD, Mort JS, Glossl J. Activation of procathepsin B in human hepatoma cells: the conversion into the mature enzyme relies on the action of cathepsin B itself. <i>Biochem J.<\/i> 1993;<b>293<\/b>:437-442.","DOI":"10.1042\/bj2930437"},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"Hirai K, Yokoyama M, Asano G, Tanaka S. Expression of cathepsin B and cystatin C in human colorectal cancer. <i>Hum Pathol.<\/i> 1999;<b>30<\/b>:680-686.","DOI":"10.1016\/S0046-8177(99)90094-1"},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Werle B, Kraft C, Lah TT, et al. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma. <i>Cancer.<\/i> 2000;<b>89<\/b>:2282-2291.","DOI":"10.1002\/1097-0142(20001201)89:11<2282::AID-CNCR17>3.0.CO;2-4"},{"key":"E00021","doi-asserted-by":"crossref","unstructured":"Eijan AM, Sandes EO, Riveros MD, et al. High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion. <i>Cancer.<\/i> 2003;<b>98<\/b>:262-268.","DOI":"10.1002\/cncr.11493"},{"key":"E00022","doi-asserted-by":"crossref","unstructured":"Liotta LA, Mandler R, Murano G, et al. Tumor cell autocrine motility factor. <i>Proc Natl Acad Sci U S A.<\/i> 1986;<b>83<\/b>:3302-3306.","DOI":"10.1073\/pnas.83.10.3302"},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Harashima N, Kurihara K, Utsunomiya A, et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. <i>Cancer Res.<\/i> 2004;<b>64<\/b>:391-399.","DOI":"10.1158\/0008-5472.CAN-03-1452"},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Franchini G, Wong-Staal F, Gallo RC. Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia. <i>Proc Natl Acad Sci U S A.<\/i> 1984;<b>81<\/b>:6207-6211.","DOI":"10.1073\/pnas.81.19.6207"},{"key":"E00025","doi-asserted-by":"crossref","unstructured":"Kinoshita T, Shimoyama M, Tobinai K, et al. Detection of mRNA for the taxl\/rexl gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. <i>Proc Natl Acad Sci U S A.<\/i> 1989;<b>86<\/b>:5620-5624.","DOI":"10.1073\/pnas.86.14.5620"},{"key":"E00026","doi-asserted-by":"crossref","unstructured":"Kannagi M, Harada S, Maruyama I, et al. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8<sup>+<\/sup> cytotoxic T cells directed against HTLV-I-infected cells. <i>Int Immunol.<\/i> 1991;<b>3<\/b>:761-767.","DOI":"10.1093\/intimm\/3.8.761"},{"key":"E00027","doi-asserted-by":"crossref","unstructured":"Tanaka Y, Oda S, Nagata K, et al. Immunological functions and phenotypes of peripheral blood lymphocytes from human T-cell leukemia virus-I carriers. <i>J Clin Immunol.<\/i> 1989;<b>9<\/b>:477-484.","DOI":"10.1007\/BF00918017"},{"key":"E00028","doi-asserted-by":"crossref","unstructured":"Hishizawa M, Imada K, Kitawaki T, Ueda M, Kadowaki N, Uchiyama T. Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals. <i>Br J Haematol.<\/i> 2004;<b>125<\/b>:568-575.","DOI":"10.1111\/j.1365-2141.2004.04956.x"},{"key":"E00029","doi-asserted-by":"crossref","unstructured":"Nakamori S, Watanabe H, Kameyama M, et al. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. <i>Cancer.<\/i> 1994;<b>74<\/b>:1855-1862.","DOI":"10.1002\/1097-0142(19941001)74:7<1855::AID-CNCR2820740705>3.0.CO;2-1"},{"key":"E00030","unstructured":"Otto T, Birchmeier W, Schmidt U, et al. Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. <i>Cancer Res.<\/i> 1994;<b>54<\/b>:3120-3123."},{"key":"E00031","doi-asserted-by":"crossref","unstructured":"Maruyama K, Watanabe H, Shiozaki H, et al. Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma. <i>Int J Cancer.<\/i> 1995;<b>64<\/b>:316-321.","DOI":"10.1002\/ijc.2910640506"},{"key":"E00032","doi-asserted-by":"crossref","unstructured":"Taniguchi K, Yonemura Y, Nojima N, et al. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor. <i>Cancer.<\/i> 1998;<b>82<\/b>:2112-2122.","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2112::AID-CNCR5>3.3.CO;2-U"},{"key":"E00033","doi-asserted-by":"crossref","unstructured":"Ohta Y, Minato H, Tanaka Y, Go T, Oda M, Watanabe Y. Autocrine motility factor receptor expression associates with tumor progression in thymoma. <i>Int J Oncol.<\/i> 2000;<b>17<\/b>:259-264.","DOI":"10.3892\/ijo.17.2.259"},{"key":"E00034","doi-asserted-by":"crossref","unstructured":"Takanami I, Takeuchi K, Watanabe H, Yanagawa T, Takagishi K, Raz A. Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer. <i>Int J Cancer.<\/i> 2001;<b>95<\/b>:384-387.","DOI":"10.1002\/1097-0215(20011120)95:6<384::AID-IJC1068>3.0.CO;2-D"},{"key":"E00035","doi-asserted-by":"crossref","unstructured":"Bellucci R, Alyea EP, Chiaretti S, et al. Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor. <i>Blood.<\/i> 2005;<b>105<\/b>:3945-3950.","DOI":"10.1182\/blood-2004-11-4463"},{"key":"E00036","doi-asserted-by":"crossref","unstructured":"Zhang M, Zhang Z, Garmestani K, et al. Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult T-cell leukemia. <i>Cancer Res.<\/i> 2004;<b>64<\/b>:5825-5829.","DOI":"10.1158\/0008-5472.CAN-04-1088"},{"key":"E00037","unstructured":"Zhang Z, Zhang M, Goldman CK, Ravetch JV, Waldmann TA. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H. <i>Cancer Res.<\/i> 2003;<b>63<\/b>:6453-6457."},{"key":"E00038","doi-asserted-by":"crossref","unstructured":"Zhang Z, Zhang M, Ravetch JV, Goldman C, Waldmann TA. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507. <i>Blood.<\/i> 2003;<b>102<\/b>:284-288.","DOI":"10.1182\/blood-2002-11-3601"},{"key":"E00039","doi-asserted-by":"crossref","unstructured":"Ishida T, Iida S, Akatsuka Y, et al. The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia\/lymphoma. <i>Clin Cancer Res.<\/i> 2004;<b>10<\/b>:7529-7539.","DOI":"10.1158\/1078-0432.CCR-04-0983"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.05173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T03:13:58Z","timestamp":1627442038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.05173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,1]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,5,1]]}},"alternative-id":["R56M8RM16387825H"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.05173","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5,1]]}}}